Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Hong Kong
Asia
Lilly-Innovent, Novartis, Moderna and more—Fierce Pharma Asia
Lilly and Innovent's PD-1 setback has implications for future players. Novartis India plans 400 layoffs. Moderna will build four new Asian branches.
Angus Liu
Feb 18, 2022 9:15am
Moderna, Eli Lilly, AstraZeneca and more—Fierce Pharma Asia
Feb 12, 2021 10:45am
An IPO will make one of the world's richest biopharma families
Jun 13, 2019 11:47am
Sanofi flu vaccine cleared in Hong Kong after impurities report
Jan 2, 2019 9:10am
HKEX, Zai Lab, WuXi and more—FiercePharmaAsia
Aug 31, 2018 9:05am
FiercePharmaAsia—Takeda-Shire, HKEX and more
May 11, 2018 9:55am
